Charles Homcy - Director, Bridgebio Pharma, Inc

As of May 18, 2022


Charles Homcy Net Worth

  • Net worth is estimated to be at least $46.15M
  • Owns at least 1,203,767 units of Bridgebio Pharma, Inc stock
  • Sold an estimated value of $5.59M in the last 3 years at Bridgebio Pharma, Inc

Charles Homcy Compensation at Bridgebio Pharma, Inc in 2020

  • Earned a $500,000 salary and a $100 bonus
  • Received a total compensation of $1,855,805

Charles Homcy Trading

  • Largest purchase of shares was 10,256 units , worth over $174.35K on October 19, 2020
  • Largest sale of shares was 99,257 units , worth over $3.67M on September 29, 2020
  • In total has made about 14 transactions over 3 years
  • Usually trades in June, October, December and March, with the busiest year in 2020
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

Charles Homcy Mailing Address

  • Mailing address is Portola Pharmaceuticals, Inc. 270 East Grand Avenue South San Francisco CA 94080 CA

Bridgebio Pharma, Inc Executive Compensation

Name
Year
Salary
Bonus
Stock Awards
Option Awards
Other Compensation
Total
Neil Kumar, Ph.D. 2020 $550,000 $825,000 $2,368,511 $6,299,998 $11,400 $10,054,909
Neil Kumar, Ph.D. 2019 $502,765 $360,000 $13,863,445 $11,573,049 $34,804 $26,334,063
Neil Kumar, Ph.D. 2018 $450,000 - - - - $450,000
Brian Stephenson, Ph.D., CFA 2020 $550,000 $712,500 $789,494 $2,099,996 $11,943 $4,163,933
Brian Stephenson, Ph.D., CFA 2019 $420,000 $189,000 $132,600 $3,430,781 $26,586 $4,198,967
Brian Stephenson, Ph.D., CFA 2018 $74,375 $330,240 $1,942,500 - - $2,347,115
Michael Henderson, M.D. 2020 $515,000 $300,000 $7,072,500 $91,899 $11,843 $7,991,241
Cameron Turtle, Ph.D.* 2020 $400,000 $210,000 $3,940,081 - $11,400 $4,561,482
Charles Homcy, M.D. 2020 $500,000 $100,000 - $1,199,992 $55,812 $1,855,805
Charles Homcy, M.D. 2019 $513,808 - $2,111,579 $3,128,716 $221,737 $5,975,842
Brian Stolz 2020 $511,362 $25,000 $736,854 $1,992,182 $1,975,453 $5,240,851
Brian Stolz 2019 $146,780 $93,750 $6,860,780 $1,045,003 - $8,146,313
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1743881/000119312521145491/d131567ddef14a.htm

Bridgebio Pharma, Inc Insider Trading

  • The most recent transaction was 12,000 units bought on March 17, 2022 by Andrea Ellis worth over $100.68K
  • In the last 3 years, insiders at Bridgebio Pharma, Inc sold an estimated value of $351.74M and bought an estimated value of $213.34M
  • The most active traders are Neil Kumar, CEO and President,  Brian C Stephenson, See Remarks,  and Thomas Michael Henderson, Chief Business Officer
  • Insider trading is most common in June, with the busiest year in 2020

BridgeBio Pharma, Inc. Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1